Literature DB >> 8458034

Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine?

H Van Belle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8458034     DOI： 10.1093/cvr/27.1.68

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  24 in total

1.  A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine.

Authors:  E Snoeck; P Jacqmin; A Van Peer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Effect of endogenous adenosine augmentation on ischemia and reperfusion injury to the liver.

Authors:  S Zhang; M B Jin; Y Zhu; N Ishizaki; H Tanaka; V M Subbotin; R G Lee; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

4.  Isolation, cloning and characterization of a low-molecular-mass purine nucleoside- and nucleotide-binding protein.

Authors:  J Gilmour; N Liang; J M Lowenstein
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3.

Authors:  Jing Zhang; Tracey Tackaberry; Mabel W L Ritzel; Taylor Raborn; Gerry Barron; Stephen A Baldwin; James D Young; Carol E Cass
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

6.  Studies of the nucleoside transporter inhibitor, draflazine, in the human myocardium.

Authors:  M Böhm; C Weinhold; R H Schwinger; J Müller-Ehmsen; D Böhm; H Reichenspurner; B Reichart; E Erdmann
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 7.  Purine metabolism in the heart. Strategies for protection against myocardial ischaemia.

Authors:  K Ver Donck
Journal:  Pharm World Sci       Date:  1994-04-15

8.  Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.

Authors:  T B McClanahan; D P Ignasiak; B J Martin; T E Mertz; K P Gallagher
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

9.  Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.

Authors:  Zhengxiang Zhu; John K Buolamwini
Journal:  Bioorg Med Chem       Date:  2008-01-30       Impact factor: 3.641

10.  Role of endogenous adenosine in the acute and late response to allergen challenge in actively sensitized Brown Norway rats.

Authors:  K M Ellis; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.